Direct Costs of Rheumatoid Arthritis among Patients with Biological Therapy in Morocco: ECORAM Study
Hanae Zarrik(Mohammed V University), Samir Ahid(Mohammed V University), R. Bahiri(Centre Hospitalier Universitaire de Rabat-Salé), F. Allali(Délégation Paris 5), Laila Lahlou(Université Ibn Zohr), Abha Cherkani Hassani(Mohammed V University), Hanan Rkain(Hôpital El Ayachi), Meriem Slaoui(Mohammed V University)
Cited by 2
Related Papers
Why we should definitely include intra-articular hyaluronic acid as a therapeutic option in the management of knee osteoarthritis: Results of an extensive critical literature review
|Seminars in Arthritis and Rheumatism|2018|164
High Prevalence of Hypovitaminosis D in Morocco: Relationship to Lifestyle, Physical Performance, Bone Markers, and Bone Mineral Density
|Seminars in Arthritis and Rheumatism|2008|154
Increase in bone mineral density of patients with spondyloarthropathy treated with anti-tumour necrosis factor α
|Annals of the Rheumatic Diseases|2003|122
Sarcopenia in rheumatoid arthritis: prevalence, influence of disease activity and associated factors
|Rheumatology International|2017|114